Literature DB >> 11489728

Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer.

W J Aronson1, J A Glaspy, S T Reddy, D Reese, D Heber, D Bagga.   

Abstract

OBJECTIVES: The results of epidemiologic and animal studies support the role of a low-fat diet supplemented with omega-3 fatty acids contained in fish oil in preventing the development and progression of prostate cancer. As a first step in studying the role of a low-fat, fish oil-supplemented (LF/FOS) diet in a clinical setting, we conducted a prospective study in men with untreated prostate cancer to evaluate whether a 3-month dietary intervention affects the ratio of omega-3 to omega-6 fatty acids in plasma and gluteal fat. In addition, we evaluated the feasibility of studying cyclooxygenase-2 (COX-2) expression in serial prostate needle biopsy specimens before and after the diet.
METHODS: Nine men with untreated prostate cancer consumed an LF/FOS diet for 3 months. Plasma, gluteal adipose tissue, and prostate needle biopsy specimens were obtained from each patient before and after the intervention. The fatty acid compositions of the plasma and gluteal adipose tissue were determined by gas-liquid chromatography, and the COX-2 expression in the prostatic tissue specimens was determined by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR).
RESULTS: Short-term intervention with an LF/FOS diet caused a significant increase in the omega-3/omega-6 fatty acid ratio in plasma (P = 0.002) and gluteal adipose tissue (P = 0.002) in men with prostate cancer. The COX-2 expression in prostatic tissue was quantitated by RT-PCR in 7 of 9 patients, and COX-2 expression decreased in 4 of these 7 patients.
CONCLUSIONS: A short-term dietary intervention in men with prostate cancer leads to a significant increase in the omega-3/omega-6 fatty acid ratios in plasma and adipose tissue. The potential for this diet to prevent the development and progression of prostate cancer by way of altered COX-2 expression and prostaglandin production in prostatic tissue requires further study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489728     DOI: 10.1016/s0090-4295(01)01116-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  27 in total

1.  Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Authors:  Lisa D Yee; Joanne L Lester; Rachel M Cole; Julia R Richardson; Jason C Hsu; Yan Li; Amy Lehman; Martha A Belury; Steven K Clinton
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

2.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

3.  Fish oil rich in eicosapentaenoic acid protects against oxidative stress-related renal dysfunction induced by TCDD in Wistar rats.

Authors:  Kalai Selvi Palaniswamy; Vijaya Padma Vishwanadha; Saranya Ramalingam Singaravelu
Journal:  Cell Stress Chaperones       Date:  2013-10-11       Impact factor: 3.667

4.  RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Authors:  Janel Suburu; Kyu Lim; Gabriella Calviello; Yong Q Chen
Journal:  J Natl Cancer Inst       Date:  2014-03-31       Impact factor: 13.506

5.  Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.

Authors:  Gillian Hawcroft; Paul M Loadman; Andrea Belluzzi; Mark A Hull
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

6.  Dietary habits and prostate cancer detection: a case-control study.

Authors:  Moamen Amin; Suganthiny Jeyaganth; Nader Fahmy; Louis R Bégin; Samuel Aronson; Stephen Jacobson; Simon Tanguay; Wassim Kassouf; Armen Aprikian
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

Review 7.  Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer.

Authors:  Adam C Reese; Vincent Fradet; John S Witte
Journal:  J Nutrigenet Nutrigenomics       Date:  2009-09-23

8.  Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion.

Authors:  Dilprit Bagga; Ling Wang; Robin Farias-Eisner; John A Glaspy; Srinivasa T Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

9.  The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs.

Authors:  Lisa D Yee; Deepak Agarwal; Thomas J Rosol; Amy Lehman; Min Tian; Jennifer Hatton; Jessica Heestand; Martha A Belury; Steven K Clinton
Journal:  Mol Nutr Food Res       Date:  2012-12-05       Impact factor: 5.914

Review 10.  Multi-targeted therapy of cancer by omega-3 fatty acids.

Authors:  Isabelle M Berquin; Iris J Edwards; Yong Q Chen
Journal:  Cancer Lett       Date:  2008-05-13       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.